TXNDC9 Expression in Colorectal Cancer Cells and Its Influence on Colorectal Cancer Prognosis
Overview
Authors
Affiliations
In this study, we analyzed the protein expression of thioredoxin domain containing 9 (TXNDC9) in 116 colorectal cancer (CRC) cases. Among them, 97 were positive in CRC tissues and 60 were positive in normal mucosa. TXNDC9 expression in CRC was correlated with the extent of tumor invasion and the tumor size. TXNDC9-negative patients had longer lifespans. In vitro assays showed the significant suppression of CRC cell proliferation (P < .01) compared with two control groups; the number of invaded cells also decreased (P < .01). These findings suggest that TXNDC9 gene may function in cancer development and may be an effective target for inhibiting the growth and metastasis of CRC cells.
TXNDC9 knockdown inhibits lung adenocarcinoma progression by targeting YWHAG.
Wang J, Pan X, Li J, Zhao J Mol Med Rep. 2022; 25(6).
PMID: 35485284 PMC: 9073845. DOI: 10.3892/mmr.2022.12719.
The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies.
Jaganjac M, Milkovic L, Sunjic S, Zarkovic N Antioxidants (Basel). 2020; 9(11).
PMID: 33228209 PMC: 7699519. DOI: 10.3390/antiox9111151.
Chen D, Zou J, Zhao Z, Tang X, Deng Z, Jia J Cell Death Dis. 2018; 9(11):1110.
PMID: 30382079 PMC: 6208382. DOI: 10.1038/s41419-018-1150-4.
Cho S, Kim S, Son M, Rou W, Kim S, Eun H Dig Dis Sci. 2018; 64(1):123-136.
PMID: 30288659 DOI: 10.1007/s10620-018-5307-x.
Network-Based Enriched Gene Subnetwork Identification: A Game-Theoretic Approach.
Razi A, Afghah F, Singh S, Varadan V Biomed Eng Comput Biol. 2016; 7(Suppl 2):1-14.
PMID: 27081328 PMC: 4822726. DOI: 10.4137/BECB.S38244.